Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-gu-2018/asco-gu-2018-prostate-cancer/101812-asco-gu-2018-overall-survival-of-patients-with-metastatic-prostate-cancer-starting-adt-with-degarelix-a-gonadotropin-releasing-hormone-antagonist.html
If you do not want to visit that page, you can close this browser tab.
